Chemoinformaics analysis of 1-ethyl-4-methoxy-9H-pyrido[3,4-b]indol-8-ol
Molecular Weight | 242.278 | nRot | 2 |
Heavy Atom Molecular Weight | 228.166 | nRig | 15 |
Exact Molecular Weight | 242.106 | nRing | 3 |
Solubility: LogS | -3.416 | nHRing | 2 |
Solubility: LogP | 3.06 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
No. of Oxygen atom | 2 | No. of Arom Bond | 15 |
nHA | 3 | APOL | 36.5191 |
nHD | 2 | BPOL | 17.4909 |
QED | 0.726 |
Synth | 2.544 |
Natural Product Likeliness | 0.932 |
NR-PPAR-gamma | 0.939 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.018 |
HIA | 0.011 |
CACO-2 | -4.898 |
MDCK | 0.0000137 |
BBB | 0.152 |
PPB | 0.94223 |
VDSS | 0.978 |
FU | 0.0545315 |
CYP1A2-inh | 0.991 |
CYP1A2-sub | 0.969 |
CYP2c19-inh | 0.67 |
CYP2c19-sub | 0.272 |
CYP2c9-inh | 0.78 |
CYP2c9-sub | 0.832 |
CYP2d6-inh | 0.822 |
CYP2d6-sub | 0.851 |
CYP3a4-inh | 0.459 |
CYP3a4-sub | 0.426 |
CL | 7.055 |
T12 | 0.667 |
hERG | 0.02 |
Ames | 0.623 |
ROA | 0.949 |
SkinSen | 0.705 |
Carcinogencity | 0.568 |
EI | 0.844 |
Respiratory | 0.981 |
NR-Aromatase | 0.682 |
Antiviral | Yes |
Prediction | 0.645045 |